Single-agent therapy with bicalutamide: A comparison with medical or surgical castration in the treatment of advanced prostate carcinoma
- 1 December 1995
- Vol. 46 (6) , 849-855
- https://doi.org/10.1016/s0090-4295(99)80356-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Health-related quality of life in patients with advanced prostate cancer: A multinational perspectiveQuality of Life Research, 1995
- A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancerUrology, 1995
- Current clinical studies with a new nonsteroidal antiandrogen, casodexThe Prostate, 1994
- Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853)Urology, 1993
- Clinical profile of a new non-steroidal antiandrogenThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- A Controlled Trial of Castration With and Without Nilutamide in Metastatic Prostatic CarcinomaCancer, 1990
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scanCancer, 1988
- Flutamide as Primary Treatment for Metastatic Prostatic CancerBritish Journal of Urology, 1987
- STUDIES ON PROSTATIC CANCERArchives of Surgery, 1941